Cargando…

DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.

Microscopic malignancy grading using the 8-factor system proposed by Jakobsson et al. (1973), the 4-factor system set up by Glanz and Eichhorn (1985), and DNA cytofluorometry were applied to thirteen T1 and thirty-seven T2 squamous cell carcinomas of the oral cavity, 9 with and 41 without metastases...

Descripción completa

Detalles Bibliográficos
Autores principales: Tytor, M., Franzén, G., Olofsson, J., Brunk, U., Nordenskjöld, B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001903/
https://www.ncbi.nlm.nih.gov/pubmed/3426931
_version_ 1782135683961323520
author Tytor, M.
Franzén, G.
Olofsson, J.
Brunk, U.
Nordenskjöld, B.
author_facet Tytor, M.
Franzén, G.
Olofsson, J.
Brunk, U.
Nordenskjöld, B.
author_sort Tytor, M.
collection PubMed
description Microscopic malignancy grading using the 8-factor system proposed by Jakobsson et al. (1973), the 4-factor system set up by Glanz and Eichhorn (1985), and DNA cytofluorometry were applied to thirteen T1 and thirty-seven T2 squamous cell carcinomas of the oral cavity, 9 with and 41 without metastases. There was a significant correlation between the presence of lymph node metastases (N1) and the malignancy scores (P less than 0.05) and tumour DNA ploidy (P less than 0.01, chi-square). The total number of patients with initial and late lymph node metastases correlated significantly with polyploid nuclei (P less than 0.05) and with malignancy scores (P less than 0.001), which also correlated with regional recurrences (P less than 0.01, chi-square). No remaining tumour after preoperative radiotherapy indicated less risk for local recurrence than if tumour persisted (P less than 0.01, chi-square). The cumulative survival (Kaplan-Meier) was worse for patients with nodal involvement (N1) than for those without (N0) (P less than 0.01), and for patients with poorly differentiated tumours compared with moderately well differentiated (P less than 0.05) and to well differentiated (P less than 0.001). The prognosis was worse for patients with high malignancy scores than those with low (P less than 0.001). DNA diploid tumours had a better prognosis than DNA non-diploid, but the difference was not significant.
format Text
id pubmed-2001903
institution National Center for Biotechnology Information
language English
publishDate 1987
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20019032009-09-10 DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas. Tytor, M. Franzén, G. Olofsson, J. Brunk, U. Nordenskjöld, B. Br J Cancer Research Article Microscopic malignancy grading using the 8-factor system proposed by Jakobsson et al. (1973), the 4-factor system set up by Glanz and Eichhorn (1985), and DNA cytofluorometry were applied to thirteen T1 and thirty-seven T2 squamous cell carcinomas of the oral cavity, 9 with and 41 without metastases. There was a significant correlation between the presence of lymph node metastases (N1) and the malignancy scores (P less than 0.05) and tumour DNA ploidy (P less than 0.01, chi-square). The total number of patients with initial and late lymph node metastases correlated significantly with polyploid nuclei (P less than 0.05) and with malignancy scores (P less than 0.001), which also correlated with regional recurrences (P less than 0.01, chi-square). No remaining tumour after preoperative radiotherapy indicated less risk for local recurrence than if tumour persisted (P less than 0.01, chi-square). The cumulative survival (Kaplan-Meier) was worse for patients with nodal involvement (N1) than for those without (N0) (P less than 0.01), and for patients with poorly differentiated tumours compared with moderately well differentiated (P less than 0.05) and to well differentiated (P less than 0.001). The prognosis was worse for patients with high malignancy scores than those with low (P less than 0.001). DNA diploid tumours had a better prognosis than DNA non-diploid, but the difference was not significant. Nature Publishing Group 1987-11 /pmc/articles/PMC2001903/ /pubmed/3426931 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Tytor, M.
Franzén, G.
Olofsson, J.
Brunk, U.
Nordenskjöld, B.
DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.
title DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.
title_full DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.
title_fullStr DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.
title_full_unstemmed DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.
title_short DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.
title_sort dna content, malignancy grading and prognosis in t1 and t2 oral cavity carcinomas.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001903/
https://www.ncbi.nlm.nih.gov/pubmed/3426931
work_keys_str_mv AT tytorm dnacontentmalignancygradingandprognosisint1andt2oralcavitycarcinomas
AT franzeng dnacontentmalignancygradingandprognosisint1andt2oralcavitycarcinomas
AT olofssonj dnacontentmalignancygradingandprognosisint1andt2oralcavitycarcinomas
AT brunku dnacontentmalignancygradingandprognosisint1andt2oralcavitycarcinomas
AT nordenskjoldb dnacontentmalignancygradingandprognosisint1andt2oralcavitycarcinomas